David Graham

Physician

24

Who is David Graham?

David J. Graham is an American epidemiologist who is the Associate Director of the Food and Drug Administration's Office of Drug Safety.

Graham has spent his career at the FDA studying the safety of drugs, many of them after approval using data from medical insurance companies. He claims successes in removing from the U.S. market the unsafe drugs Omniflox an antibiotic, Rezulin, a diabetes treatment, Fen-Phen and Redux, weight-loss drugs, and phenylpropanolamine, an over-the-counter decongestant, and in restricting the use of Trovan, an antibiotic, to use in hospitals. He also had a part in the removal of Lotronex, Baycol, Seldane, and Propulsid.

On November 18, 2004, Dr. Graham testified before the U.S. Senate Committee on Finance about Merck's withdrawal of the popular anti-inflammatory drug Vioxx the previous month because of serious safety concerns. In his testimony, he asserted his personal belief that the policies within the U.S. Food and Drug Administration were insufficient to protect the public from drugs which carry unacceptable risks, saying "I would argue that the FDA, as currently configured, is incapable of protecting America against another Vioxx. We are virtually defenseless."

We need you!

Help us build the largest biographies collection on the web!

Profession

Submitted
on July 23, 2013

Citation

Use the citation below to add to a bibliography:

Style:MLAChicagoAPA

"David Graham." Biographies.net. STANDS4 LLC, 2022. Web. 8 Dec. 2022. <https://www.biographies.net/biography/david-graham/m/05019k>.

Discuss this David Graham biography with the community:

0 Comments

    Browse Biographies.net